scholarly journals Views about integrating smoking cessation treatment within psychological services for patients with common mental illness: A multi‐perspective qualitative study

2020 ◽  
Author(s):  
Gemma M. J. Taylor ◽  
Katherine Sawyer ◽  
David Kessler ◽  
Marcus R. Munafò ◽  
Paul Aveyard ◽  
...  
2020 ◽  
Author(s):  
Gemma Taylor ◽  
Katherine Sawyer ◽  
David Kessler ◽  
Marcus Munafò ◽  
Paul Aveyard ◽  
...  

ABSTRACTBackgroundSmoking rates are significantly higher in people with mental health problems, compared to those without. Negative attitudes towards smoking cessation are widespread in inpatient settings towards patients with severe and enduring mental illness. It is not clear if the same attitudes operate in psychological services towards people with common mental illness. We aimed to understand the concerns and views that patients, therapists, and smoking cessation practitioners may have about integrating smoking cessation treatment into psychological treatment for common mental illness and how these concerns may be overcome.MethodsThematic analysis of 23 in-depth interviews. Interviews took place in Improving Access to Psychological Therapies (IAPT) and smoking cessation services in England. Participants were 11 psychological wellbeing practitioners (PWPs), six IAPT patients with common mental illness, and six smoking cessation advisors.OutcomesNone.FindingsIAPT patients reported psychological benefits from smoking, but also described smoking as a form of therapeutic self-harm. PWPs seem positive towards smoking cessation treatment for people with common mental illness. IAPT PWPs and patients accept evidence that smoking tobacco may harm mental health, and quitting might benefit mental health. PWPs report expertise in helping people with common mental illness to make behavioural changes in the face of mood disturbances and poor motivation. IAPT appears to be a natural environment for smoking cessation intervention. PWPs felt confident to offer smoking cessation treatments to IAPT patients, but thought that a reduction in caseload was required to deliver smoking cessation support in an already pressed service.


2019 ◽  
Vol 22 (9) ◽  
pp. 1533-1542 ◽  
Author(s):  
Roger Vilardaga ◽  
Javier Rizo ◽  
Paige E Palenski ◽  
Paolo Mannelli ◽  
Jason A Oliver ◽  
...  

Abstract Introduction High rates of tobacco use among people with serious mental illness (SMI), along with their unique needs, suggest the importance of developing tailored smoking cessation interventions for this group. Previous early-phase work empirically validated the design and content of Learn to Quit, a theory-based app designed for this population. Methods In a pilot randomized controlled trial, we compared the feasibility, acceptability, and preliminary efficacy of Learn to Quit versus QuitGuide, an app designed for the general population. All participants received nicotine replacement therapy and technical assistance. Daily smokers with SMI (N = 62) participated in the trial with outcomes assessed at weeks 4, 8, 12, and 16. Results Compared to QuitGuide, Learn to Quit participants had similar number of days of app use (34 vs. 32, p = .754), but larger number of app interactions (335 vs. 205; p = .001), longer durations of app use (4.24 hrs. vs. 2.14 hrs; p = .044), and higher usability scores (85 vs. 79, p = .046). At week 16, Learn to Quit led to greater reductions in cigarettes per day (12.3 vs. 5.9 for QuitGuide; p = 0.10). Thirty-day point prevalence abstinence was verified in 12% of Learn to Quit participants versus 3% of QuitGuide participants (odds ratio = 3.86, confidence interval = 0.41 to 36, p = .239). Changes in psychiatric symptoms and adverse events were not clinically significant between conditions. Conclusions This pilot trial provides strong evidence of Learn to Quit’s usability, feasibility, and safety. Preliminary evidence suggests the app may be efficacious. A randomized controlled efficacy trial is needed to test the app in a larger sample of smokers with SMI. Implications This study suggests that the Learn to Quit app is a feasible approach to deliver smoking cessation treatment in patients with co-occurring tobacco use disorder and SMI. This means that, if found efficacious, this technology could be used to deploy smoking cessation treatment to larger segments of this population, hence improving public health. Therefore, a randomized controlled trial should be conducted to examine the efficacy of this digital intervention.


Author(s):  
Eva Anne Marije van Eerd ◽  
Mette Bech Risør ◽  
Mark Spigt ◽  
Maciek Godycki-Cwirko ◽  
Elena Andreeva ◽  
...  

2018 ◽  
Vol 69 (8) ◽  
pp. 849-851 ◽  
Author(s):  
Li-Shiun Chen ◽  
Timothy B. Baker ◽  
Jeanette M. Korpecki ◽  
Kelly E. Johnson ◽  
Jaime P. Hook ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document